Blood-Test Startups Try to Crawl Out From the Shadow of Elizabeth Holmes

(Bloomberg) -- As Daniel Levner tells it, the “Theranos effect” came in three distinct waves. First, he says, when the company was at its peak, many investors wouldn’t bother funding other blood-te...